This week, seven Medical Devices stocks are improving their overall rating on Portfolio Grader. Each of these rates an “A” (“strong buy”) or “B” overall (“buy”).
OraSure Technologie (NASDAQ:OSUR) is making progress this week as its rating of C (“hold”) from last week increases to a B (“buy”) rating this week. OraSure Technologies develops, manufactures, and markets medical devices and diagnostic products. For more information, get Portfolio Grader’s complete analysis of OSUR stock.
Align Technology (NASDAQ:ALGN) is making headway this week, with the company’s rating improving to an A (“strong buy”) from a B (“buy”) last week. Align Technology designs, manufactures, and markets the Invisalign system, which is a proprietary method for treating aligning teeth. The price of ALGN is up 1.4% since last month. For more information, get Portfolio Grader’s complete analysis of ALGN stock.
Exactech‘s (NASDAQ:EXAC) ratings are looking better this week, moving up to a B from last week’s C. Exactech develops, manufactures, markets, and sells orthopedic implant devices and related surgical instrumentation. EXAC shares are up 3.6% from a month ago. For more information, get Portfolio Grader’s complete analysis of EXAC stock.
This week, West Pharmaceutical Services‘s (NYSE:WST) ratings are up from a C last week to a B. West Pharmaceutical is a manufacturer of components and systems for injectable drug delivery, and plastic packaging and delivery system components for the healthcare and consumer products industries. For more information, get Portfolio Grader’s complete analysis of WST stock.
Sirona Dental Systems (NASDAQ:SIRO) improves from a C to a B rating this week. Sirona Dental Systems is a manufacturer of high-quality, technologically-advanced dental equipment, and is focused on developing, manufacturing and marketing innovative solutions for dentists around the world. Shares of SIRO have increased 24.7% over the past month, better than the 5.2% increase the Nasdaq has seen over the same period of time. For more information, get Portfolio Grader’s complete analysis of SIRO stock.
The rating of Cooper (NYSE:COO) moves up this week, rising from a C to a B. Cooper develops, manufactures, and markets healthcare products. Investors seem to agree with the upgraded status of the stock, and have pushed the stock up 9.8% over the past month. For more information, get Portfolio Grader’s complete analysis of COO stock.
Novadaq Technologies‘s (NASDAQ:NVDQ) ratings are looking better this week, moving up to an A from last week’s B. Novadaq Technologies develops and commercializes medical devices based on its proprietary imaging platform for the diagnosis and treatment of human vascular and opthalmic diseases and conditions. For more information, get Portfolio Grader’s complete analysis of NVDQ stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.